Search for: "Genetic Technologies Limited" Results 401 - 420 of 983
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 May 2018, 7:55 am
Finally, Meredith Jacob suggests a set of best practices for both pledgors and pledgees with the aim of improving “the usefulness and enforceability of patent pledges”.Some selected patent pledges made by Tesla Motors, IBM, Google, Myriad Genetics, Monsanto, Red Hat, and Microsoft are included in the appendix of the book.Patent Pledges Global Perspectives on Patent Law’s Private Ordering Frontier, is a must-read for anyone involved in technology development and… [read post]
3 May 2018, 5:57 am by Dan Filler
Authors and presenters are invited to submit proposals on topics including but not limited to the following: New and Evolving Technologies• Internet of Things (IoT)• Data Analytics• Professional Duties for Lawyers• TRIPS and Other Trade Agreements• Virtual Reality• Cybersecurity • Evolution of Media• Advertising and Marketing• Artificial Intellegince Entrepreneurship• Ideation and Ownership• Meaningful Disclosure in Tech… [read post]
2 May 2018, 1:27 am by Orin Kerr
But if so, I wonder if that's more a story of technological growing pains than government overreach. [read post]
23 Apr 2018, 9:56 am by Kevin M. Mazza, Esq.
In-vitro fertilization and implantation technology enabled a woman to be implanted with an embryo with whom she had no genetic connection, and carry that pregnancy to term. [read post]
23 Apr 2018, 9:56 am by Kevin M. Mazza, Esq.
In-vitro fertilization and implantation technology enabled a woman to be implanted with an embryo with whom she had no genetic connection, and carry that pregnancy to term. [read post]
22 Apr 2018, 9:00 am by Michael H Cohen
The CURES Act codifies the way FDA has regulated clinical decision-making software, but is this better or worse for healthcare startups that are trying to position their software within the CDS model? [read post]
21 Apr 2018, 7:22 am by Ashley Ahlbrand
This special issue of EDPL will explore the impact of the new EU data protection legislation in the field of medicine and health by looking at the following topics: Anonymisation and pseudonymisation of health and genetic data Data portability as applicable to the medical/health data Legal grounds for processing health/genetic data other than consent in particular Article 9 g-i-h-j of GDPR National conditions and limitations for the use of health and genetic data… [read post]
5 Apr 2018, 9:19 am by Guy Burgess
This is learning-based information as opposed to genetically-based information. [read post]
1 Apr 2018, 9:30 pm by Erin Quick
Thanks to rapid advances in genetic technology, scientists can give cells cancer-fighting capabilities and improve athletic performance with genes that help build muscle faster. [read post]
12 Mar 2018, 5:08 pm by Heather Joy
Potential topics include (but are not limited to): •Artificial intelligence •Autonomous vehicles •Bitcoin and other blockchain technologies •Computational law •Customized medicine •Genetics and epigenetics •Machine learning and predictive analytics •Nanotechnology •Online security and privacy •Regulation of online platforms •Robotics •Synthetic biology   [read post]
2 Mar 2018, 5:07 am
Personalised medicine, where individual differences (genetic and others) are taken into consideration in diagnostics or drug subscription is another important application. [read post]
22 Feb 2018, 10:00 pm
The ability to obtain and defend such IP protection in genomics is a positive result for companies investing in improving genetics and bringing innovative technologies to market across plant and animal species. [read post]
1 Feb 2018, 2:00 am by Ruth Carter
This is a rule that every organization should have: only those who need access to the data subject’s information should have it, and it should be limited to only for the tasks for which they need it. [read post]
28 Jan 2018, 10:08 pm by News Desk
Encountering high temperatures is the main factor limiting where and when broccoli is grown. [read post]
15 Jan 2018, 10:00 pm by Eszter Szakács
Namely, many SPCs were granted before the Seattle Genetics interpretation, resulting in shorter terms than under Seattle Genetics, and many of them already ran out of the national appeal terms. [read post]
20 Dec 2017, 11:09 am by Kevin LaCroix
 A fundamental limitation of the Directive was that it did not require EU member states to pass one standard text into law. [read post]
10 Dec 2017, 5:03 pm by Omar Ha-Redeye
Molecular medicine and medical genetics are at the forefront of new and emerging health technologies. [read post]
15 Nov 2017, 7:40 pm
We are also on the cusp of a huge and disruptive wave of global technological change. [read post]